These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16685647)

  • 41. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian surface epithelium: family history and early events in ovarian cancer.
    Wong AS; Auersperg N
    Reprod Biol Endocrinol; 2003 Oct; 1():70. PubMed ID: 14609432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Loss of heterozygosity and microsatellite instability in the region including BRCA1 of breast cancer in Chinese].
    Cui J; Shen F; Jiang F; Wang Y; Bian J; Shen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):348-50. PubMed ID: 9845764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
    Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
    Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
    Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
    Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast.
    Caduff RF; Svoboda-Newman SM; Ferguson AW; Frank TS
    Virchows Arch; 1999 Jun; 434(6):517-22. PubMed ID: 10394886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
    Rzepecka IK; Szafron L; Stys A; Bujko M; Plisiecka-Halasa J; Madry R; Osuch B; Markowska J; Bidzinski M; Kupryjanczyk J
    Cancer Genet; 2012 Mar; 205(3):94-100. PubMed ID: 22469508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis.
    Peelen T; de Leeuw W; van Lent K; Morreau H; van Eijk R; van Vliet M; Wijnen J; Ligtenberg M; Ginjaar HB; Zweemer R; Menko F; Fodde R; van Ommen GJ; Vasen HF; Cornelisse CJ; Devilee P
    Int J Cancer; 2000 Dec; 88(5):778-82. PubMed ID: 11072248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer.
    Buekers TE; Lallas TA; Buller RE
    Gynecol Oncol; 2000 Mar; 76(3):418-22. PubMed ID: 10684722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.
    Zikan M; Bohm J; Pavlista D; Cibula D
    Clin Transl Oncol; 2011 Sep; 13(9):652-5. PubMed ID: 21865136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
    Okada S; Tokunaga E; Kitao H; Akiyoshi S; Yamashita N; Saeki H; Oki E; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 May; 19(5):1499-507. PubMed ID: 22179631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of BRCA1 gene in hereditary breast and ovarian cancer.
    Xiaoman D; Jinghe L
    Chin Med Sci J; 1999 Dec; 14(4):195-9. PubMed ID: 12894890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.